Evidence map›Paper›PMID 37074174›Full record

Trial reportmBio2023

Maternal Bacterial Engraftment in Multiple Body Sites of Cesarean Section Born Neonates after Vaginal Seeding-a Randomized Controlled Trial.

Noel T Mueller, Moira K Differding, Haipeng Sun, Jincheng Wang, Shira Levy, Varsha Deopujari, Lawrence J Appel, Martin J Blaser, Tanima Kundu, Ankit A Shah and 2 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Environmental and Maternal Imprints on Infant Gut Metabolic Programming.bioRxiv : the preprint server for biology · 2025
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Noel T MuellerDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Moira K DifferdingDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Haipeng SunDepartment of Biochemistry and Microbiology, Rutgers University, New Brunswick, New Jersey, USA.
Jincheng WangDepartment of Biochemistry and Microbiology, Rutgers University, New Brunswick, New Jersey, USA.
Shira LevyClinical Microbiome Unit (CMU), Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Varsha DeopujariInova Children's Hospital, Inova Health System, Falls Church, Virginia, USA.
Lawrence J AppelDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Martin J BlaserCenter for Advanced Biotechnology and Medicine, Rutgers University, New Brunswick, New Jersey, USA.ORCID 0000-0003-2447-2443
Tanima KunduCenter for Advanced Biotechnology and Medicine, Rutgers University, New Brunswick, New Jersey, USA.
Ankit A ShahInova Women's Hospital, Inova Health System, Falls Church, Virginia, USA.
Maria Gloria Dominguez BelloDepartment of Biochemistry and Microbiology, Rutgers University, New Brunswick, New Jersey, USA.ORCID 0000-0002-8879-6159
Suchitra K HouriganClinical Microbiome Unit (CMU), Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Rutgers, The State University of New Jersey · USInova Health System · USJohns Hopkins University · US

Funding

CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAININGT32HL007024 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Elizabeth Selvin · 1985 to 2026
$17.5M
Vaginal microbiome seeding and health outcomes in Cesarean-delivered neonates: a randomized controlled trialZIAAI001361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOURIGAN, SUCHITRA · 2022 to 2025
$3.9M
The Effects of Diet on the Gut Microbiome and Short Chain Fatty AcidsK01HL141589 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MUELLER, NOEL T · 2018 to 2022
$845k
NHLBI NIH HHS K01 HL141589NHLBI NIH HHS T32 HL007024
6 · The paper itself

Abstract

Children delivered by elective, prelabor Cesarean section (C-section) are not exposed to the birth canal microbiota and, in relation to vaginally delivered children, show altered microbiota development. Perturbed microbial colonization during critical early-life windows of development alters metabolic and immune programming and is associated with an increased risk of immune and metabolic diseases. In nonrandomized studies, vaginal seeding of C-section-born neonates partially restores their microbiota colonization to that of their vaginally delivered counterparts, but without randomization, confounding factors cannot be excluded. In a double-blind, randomized, placebo-controlled trial, we determined the effect of vaginal seeding versus placebo seeding (control arm) on the skin and stool microbiota of elective, prelabor C-section-born neonates (

Indexed as

Cesarean SectionMicrobiotaBacteriaChildFecesFemaleHumansInfant, NewbornPregnancySkinVaginaCesarean sectionmicrobiomemicrobiotaneonaterandomized controlled trialvaginal microbiome transfervaginal seeding

Identifiers

PMID37074174
PMCPMC10294643
OpenAlexW4366352768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.